Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023 10:00 ET
|
Telesis Bio
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
May 15, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
Telesis Bio
-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and...
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
April 27, 2023 16:05 ET
|
Telesis Bio
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter...
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp®...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023 16:05 ET
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced Daniel Gibson, Ph.D., CTO and...
Telesis Bio präsentiert auf dem RNA Leaders Europe Kongress
March 14, 2023 15:16 ET
|
Telesis Bio
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), ein führender Anbieter von automatisierten Lösungen für Multi-Omics und synthetische Biologie, gab heute bekannt, dass...
Telesis Bio s'apprête à réaliser des présentations lors du RNA Leaders Europe Congress
March 14, 2023 15:16 ET
|
Telesis Bio
SAN DIEGO, 14 mars 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ : TBIO), leader des solutions de biologie synthétique et de multiomique automatisées, a annoncé aujourd'hui que la société...